NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Alzheimer's disease

Neurobiology of Aging

Volumn 21, Issue 4, 2000, Pages 525-531

  Wang, Yunxia ^a   Santa Cruz, Karen ^a   Decarli, Charles ^a,b   Johnson, Jeffrey A ^b,c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Alzheimer's disease; NAD(P)H:quinone oxidoreductase; Neurons; Oxidative stress

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROPATHOLOGY; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOTTING, WESTERN; CELL DEATH; HIPPOCAMPUS; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATIVE STRESS; PYRAMIDAL CELLS; TAU PROTEINS;

EID: 0034622230     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00114-7     Document Type: Article

References (41)

1. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
2. Brunmark A., Cadenas E., Lind C., Segura-Aguilar J., Ernster L. DT-diaphorase-catalyzed two-electron reduction of quinone epoxides. Free Radic Biol Med. 3:1987;181-188.
3. Butterfield D.A., Hensley K., Hall N., Subramanian R., Howard B.J., et al. β-amyloid-derived free radical oxidation a fundamental process in Alzheimer's disease . Wasco W., Tanzi R.E. Molecular mechanisms of dementia. 1997;145-167 Humana Press, Totowa, NJ.
4. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol. 49:1995;127-140.
5. Chesis P.L., Levin D.E., Smith M.T., Ernster L., Ames B.N. Mutagenicity of quinones pathways of metabolic activation and detoxification . Proc Natl Acad Sci USA. 81:1984;1696-1700.
6. Dalton T., Palmiter R.D., Andrews G.K. Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res. 22:1994;5016-5023.
7. Daniel V., Tichauer Y., Sharon R. 5′-Flanking sequence of mouse glutathione S-transferase Ya gene. Nucleic Acids Res. 16:1988;351.
8. Duffy S., So A., Murphy T.H. Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. J Neurochem. 71:1998;69-77.
9. Ernster L, Danielson L, Ljunggren M. DT-diaphorase I. Purification from the soluble fraction of rat-liver cytoplasm, and properties. Biochim Biophys Acta 1962;58:171-88.
10. Ernster L., Navazio F. Soluble diaphorase in animal tissues. Acta Chemica Scandinavica. 12:1958;595-602.
11. Friling R.S., Bensimon A., Tichauer Y., Daniel V. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci USA. 87:1990;6258-6262.
12. Goodman Y., Mattson M.P. Staurosporine and K-252 compounds protect hippocampal neurons against amyloid β-peptide toxicity and oxidative injury. Brain Res. 650:1994;170-174.
13. Hensley K., Butterfield D.A., Hall N., Cole P., Subramaniam R., et al. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide. Ann NY Acad Sci. 786:1995;120-124.
14. Hensley K., Floyd R.A., Zheng N.Y., Nael R., Robinson K.A., et al. p38 kinase is activated in the Alzheimer's disease brain. J Neurochem. 72:1999;2053-2058.
15. Huggins C., Ueda N., Russo A. Azo dyes prevent hydrocarbon-induced leukemia in the rat. Proc Natl Acad Sci USA. 75:1978;4524-4527.
16. Jones P.L., Kucera G., Gordon H., Boss J.M. Cloning and characterization of the murine manganous superoxide dismutase-encoding gene. Gene. 153:1995;155-161.
17. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA. 95:1998;6448-6453.
18. Landi L., Fiorentini D., Galli M.C., Segura-Aguilar J., Beyer R.E. DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function. Free Radic Biol Med. 22:1997;329-335.
19. Lind C., Hochstein P., Ernster L. DT-diaphorase as a quinone reductase a cellular control device against semiquinone and superoxide radical formation . Arch Biochem Biophys. 216:1982;178-185.
20. Lind C., Vadi H., Ernster L. Metabolism of benzo(a)pyrene-3,6-quinone and 3-hydroxybenzo(a)pyrene in liver microsomes from 3-methylcholantrene-treated rats. A possible role of DT-diaphorase in the formation of glucuronyl conjugates. Arch Biochem Biophys. 190:1978;97-108.
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology. 34:1984;939-944.
22. McShea A., Zelasko D.A., Gerst J.L., Smith M.A. Signal transduction abnormalities in Alzheimer's disease evidence of a pathogenic stimuli . Brain Res. 815:1999;237-242.
23. Moehlenkamp J.D., Johnson J.A. Cell-specific activation of antioxidant/electrophile responsive elements and identification of an expanded core sequence in IMR-32 human neuroblastoma cells. Arch Biochem Biophys. 363:1999;98-106.
24. Mulcahy R.T., Wartman M.A., Baily H.H., Gipp J.J. Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem. 272:1997;7445-7454.
25. Murphy T.H., De Long M.J., Coyle J.T. Enhanced NAD(P)H. quinone reductase activity prevents glutamate toxicity produced by oxidative stress. J Neurochem. 56:1991;990-995.
26. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2:1989;1547-1558.
27. Murphy T.H., So A.P., Vincent S.R. Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation. J Neurochem. 70:1998;2156-2164.
28. Ng D., Kokot N., Hiura T., Faris M., Saxon A., Nel A. Macrophage activation by polycyclic aromatic hydrocarbons evidence for the involvement of stress-activated protein kinases, activator protein-1, and antioxidant response elements . J Immunol. 161:1998;942-951.
29. Okuda A., Sakai M., Muramatsu M. The structure of the rat glutathione S-transferase P gene and related pseudogenes. J Biol Chem. 262:1987;3858-3863.
30. Pike C., Burdic D., Walencewicz A., Glabe C., Cotman C. Neurodegeneration induced by β-amyloid peptides in vitro the role of peptide assembly state . J Neurosci. 13:1993;1676-1686.
31. Prestera T., Holtzclaw W.D., Zhang Y., Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA. 82:1985;8232-8236.
32. Pulford D.J., Hayes J.D. Characterization of the rat glutathione S-transferase Yc2 subunit gene, GSTA5 identification of a putative antioxidant-responsive element in the 5′-flanking region of rat GSTA5 that may mediate chemoprotection against aflatoxin B1 . Biochem J. 318:1996;75-84.
33. Raina AK, Templeton DJ, Deak JC, Perry G, Smith MA. Quinone reductase NQO1, a sensitive redox indicator, is increased in Alzheimer's disease. Redox Report 1994;4:23-7.
34. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant responsive element activation by oxidative stress and identification of the DNA consensus sequence required for functional activity . J Biol Chem. 266:1991;11632-11639.
35. Rushmore T.H., Pickett C.B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic responsive element controlling inducible expression by phenolic antioxidants. J Biol Chem. 265:1990;14648-14653.
36. Siegel D., Franklin W.A., Ross D. Immunohistochemical detection of NAD(P)H quinone oxidoreductase in human lung and lung tumors . Clin Cancer Res. 4:1998;2065-2070.
37. Tomiyama T., Asano S., Suwa Y., Molia T., Kataoka K., et al. Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro. Biochem Biophys Res Commun. 204:1994;76-83.
38. Traver R.D., Siegel D., Beall H.D., Phillips R.M., Gibson N.W., Franklin W.A., Ross D. Characterization of a polymorphism in NAD(P)H quinone oxidoreductase (DT-diaphorase) . Br J Cancer. 75:1997;69-75.
39. Wasserman WW, Fahl WE. Functional antioxidant responsive elements. Proc Natl Acad Sci USA 1997;94:5361-6.
40. Yankner B.A., Mesulam M.M. β-amyloid and the pathogenesis of Alzheimer's disease. N Engl J Med. 325:1991;1849-1857.
41. Yu R, Tan TH, Kong AT. Butylated hydroxanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J Biol Chem 1997;272:28962-70.